OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis
Min Jiang, Shaowei Ma, Zhongyan Hua, et al.
Disease Markers (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 10

Showing 10 citing articles:

Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions
Klaudia Żak, Bartłomiej Zaremba, Alicja Rajtak, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1966-1966
Open Access | Times Cited: 26

Three-Dimension-Printed Custom-Made Prosthetic Reconstructions in Bone Tumors: A Single Center Experience
Raffaele Vitiello, Maria Rosaria Matrangolo, Alessandro El Motassime, et al.
Current Oncology (2022) Vol. 29, Iss. 7, pp. 4566-4577
Open Access | Times Cited: 11

Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies
Yingying Zhang, Fang‐Hua Liu, Yali Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104525-104525
Closed Access | Times Cited: 1

Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials
Anna M. Czarnecka, Piotr Błoński, Paulina Chmiel, et al.
Oncology in Clinical Practice (2024)
Open Access | Times Cited: 1

A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: a multicenter retrospective study
Xianying Huang, Yong‐Jin Liu, Wei-Feng Liang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patients.
Archana Sasi, Shuvadeep Ganguly, Bivas Biswas, et al.
PubMed (2022) Vol. 14, Iss. 2, pp. 927-941
Closed Access | Times Cited: 4

Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data
Ibon Gurruchaga Sotés, M. Carmen Gómez-Mateo, María Eugenia Ortega Izquierdo, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 267-267
Open Access

Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin
Shin Ishihara, Koichi Ogura, Aiko Maejima, et al.
Japanese Journal of Clinical Oncology (2023) Vol. 53, Iss. 6, pp. 494-500
Closed Access | Times Cited: 1

Diagnostic and Prognostic Role of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio and Lymphocyte/Monocyte Ratio in Pediatric Sarcomas
Fatma Gülru Erdoğan, Hikmet Çi̇nka, Alparslan Yurtbay, et al.
Nigerian Journal of Clinical Practice (2024) Vol. 27, Iss. 12, pp. 1448-1455
Closed Access

Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients
Moritz Schmidt, Katrin Benzler, Ulrich M. Lauer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5798-5798
Open Access | Times Cited: 1

Page 1

Scroll to top